The Biotech Social Pact is a joint initiative of more than 80 industry CEOs in biotech and venture capital (VCs) from Europe and the US united by an ambition to deliver breakthrough medical innovations that transform patients’ lives. The group is committed to ensuring that patients and healthcare systems have sustainable development of, and access to, innovative therapies and technologies. We know that we will deliver our best if we are committed to a common set of principles. Our contributions to Europe will improve public health, generate vital investment and boost economic growth across the region as we expand our research activities and partnerships.